Susquehanna International Group
UTHR icon

Susquehanna International Group’s United Therapeutics UTHR Stock Holding History

Susquehanna International Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212M Buy
356,800
+51,700
+17% +$25.7M 0.02% 499
2025
Q4 		$149M Sell
305,100
-44,400
-13% -$20.7M 0.02% 661
2025
Q3 		$147M Buy
349,500
+245,100
+235% +$82.4M 0.02% 677
2025
Q2 		$30M Buy
104,400
+71,300
+215% +$21.3M ﹤0.01% 1610
2025
Q1 		$10.2M Sell
33,100
-16,800
-34% -$5.76M ﹤0.01% 2514
2024
Q4 		$17.6M Sell
49,900
-43,900
-47% -$16.1M ﹤0.01% 1982
2024
Q3 		$33.6M Sell
93,800
-28,000
-23% -$9.46M 0.01% 1380
2024
Q2 		$38.8M Buy
121,800
+51,900
+74% +$13.7M 0.01% 1163
2024
Q1 		$16.1M Buy
69,900
+24,200
+53% +$5.46M ﹤0.01% 2029
2023
Q4 		$10M Sell
45,700
-3,100
-6% -$715K ﹤0.01% 2642
2023
Q3 		$11M Sell
48,800
-5,400
-10% -$1.24M ﹤0.01% 2427
2023
Q2 		$12M Sell
54,200
-11,200
-17% -$2.48M ﹤0.01% 2293
2023
Q1 		$14.6M Buy
65,400
+17,500
+37% +$4.31M ﹤0.01% 2011
2022
Q4 		$13.3M Sell
47,900
-39,100
-45% -$9.87M ﹤0.01% 1917
2022
Q3 		$18.2M Sell
87,000
-57,500
-40% -$12.9M ﹤0.01% 1504
2022
Q2 		$34M Buy
144,500
+81,500
+129% +$16.6M 0.01% 1065
2022
Q1 		$11.3M Buy
63,000
+5,300
+9% +$1.01M ﹤0.01% 2393
2021
Q4 		$12.5M Sell
57,700
-1,000
-2% -$196K ﹤0.01% 2428
2021
Q3 		$10.8M Sell
58,700
-1,100
-2% -$217K ﹤0.01% 2748
2021
Q2 		$10.7M Buy
59,800
+16,000
+37% +$3.05M ﹤0.01% 2818
2021
Q1 		$7.33M Buy
43,800
+37,900
+642% +$6.32M ﹤0.01% 3274
2020
Q4 		$896K Sell
5,900
-6,200
-51% -$814K ﹤0.01% 6963
2020
Q3 		$1.22M Sell
12,100
-35,800
-75% -$3.93M ﹤0.01% 5634
2020
Q2 		$5.8M Sell
47,900
-17,300
-27% -$1.95M ﹤0.01% 2795
2020
Q1 		$6.18M Buy
65,200
+9,700
+17% +$922K ﹤0.01% 2309
2019
Q4 		$4.89M Buy
55,500
+14,000
+34% +$1.23M ﹤0.01% 2991
2019
Q3 		$3.31M Sell
41,500
-600
-1% -$48.3K ﹤0.01% 3334
2019
Q2 		$3.29M Sell
42,100
-46,400
-52% -$4.34M ﹤0.01% 3307
2019
Q1 		$10.4M Buy
88,500
+63,400
+253% +$7.39M ﹤0.01% 1711
2018
Q4 		$2.73M Sell
25,100
-52,600
-68% -$6.1M ﹤0.01% 3065
2018
Q3 		$9.94M Sell
77,700
-81,300
-51% -$10.1M ﹤0.01% 1941
2018
Q2 		$18M Buy
159,000
+114,900
+261% +$12.6M 0.01% 1392
2018
Q1 		$4.96M Sell
44,100
-12,500
-22% -$1.59M ﹤0.01% 2547
2017
Q4 		$8.37M Sell
56,600
-18,600
-25% -$2.36M ﹤0.01% 1987
2017
Q3 		$8.81M Buy
75,200
+51,500
+217% +$6.58M ﹤0.01% 1883
2017
Q2 		$3.08M Sell
23,700
-40,500
-63% -$5.05M ﹤0.01% 3104
2017
Q1 		$8.69M Buy
64,200
+1,200
+2% +$182K ﹤0.01% 1753
2016
Q4 		$9.04M Buy
63,000
+3,000
+5% +$383K ﹤0.01% 1662
2016
Q3 		$7.08M Sell
60,000
-27,300
-31% -$3.28M ﹤0.01% 1846
2016
Q2 		$9.25M Sell
87,300
-34,300
-28% -$3.83M 0.01% 1516
2016
Q1 		$13.6M Buy
121,600
+16,000
+15% +$2.02M 0.01% 1282
2015
Q4 		$16.5M Buy
105,600
+8,800
+9% +$1.28M 0.01% 1290
2015
Q3 		$12.7M Sell
96,800
-27,000
-22% -$4.33M 0.01% 1606
2015
Q2 		$21.5M Sell
123,800
-75,800
-38% -$13.6M 0.01% 1246
2015
Q1 		$34.4M Buy
199,600
+38,300
+24% +$5.84M 0.02% 849
2014
Q4 		$20.9M Sell
161,300
-85,400
-35% -$11M 0.01% 1327
2014
Q3 		$31.7M Buy
246,700
+31,300
+15% +$3.23M 0.01% 1032
2014
Q2 		$19.1M Buy
215,400
+149,100
+225% +$14.3M 0.01% 1446
2014
Q1 		$6.23M Buy
66,300
+15,400
+30% +$1.58M ﹤0.01% 2582
2013
Q4 		$5.76M Buy
50,900
+23,500
+86% +$2.12M ﹤0.01% 2748
2013
Q3 		$2.16M Sell
27,400
-58,200
-68% -$4.25M ﹤0.01% 3970
2013
Q2 		$5.63M Buy
+85,600
New +$5.51M ﹤0.01% 2469

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Susquehanna International Group's UTHR Position: Q1 2026 in Review

Susquehanna International Group increased its United Therapeutics (UTHR) stake by 117% in Q1 2026, buying an estimated $7.97M and bringing the position to 29,696 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

Susquehanna International Group first reported a position in UTHR in Q2 2013 and has held it in 41 quarters since. The position peaked at $74M in Q3 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Susquehanna International Group held 29,696 shares of United Therapeutics worth $17.6M as of Q1 2026.
  • Susquehanna International Group bought 16,004 United Therapeutics shares in Q1 2026, an estimated $7.97M.
  • United Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2387 holding.
  • Susquehanna International Group first reported a position in United Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's United Therapeutics position peaked at $74M in Q3 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.